Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This is an 8 week study for patients who are currently taking antidepressant medication but
not fully responding. Ropinirole CR would be taken in conjunction with current antidepressant
medication. Patients come into the clinic once a week when starting on the medication and
then once every other week for the remainder of the 8 weeks.